Pfizer's shares take a nosedive after a disappointing forecast for next year, revealing that its ambitious $43 billion takeover of seagen may not be enough to counter the diminishing returns from its covid franchise.

Pfizer struggles amid Covid decline

pfizer-stocks

Pfizer Stocks, News on Pfizer Stocks, stories on Pfizer Stocks, articles on Pfizer Stocks, Pfizer Stocks stories at Wion, Pfizer Stocks news, Pfizer Stocks latest news

pfizer stocks

Pfizer struggles amid Covid decline